- Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaroon April 30, 2024 at 3:04 pm
Zepbound reported $517.4 million in sales for the quarter, even as most doses of the drug slipped into shortages in the U.S.
- Walmart to shutter health centers, virtual care service in latest failed push into health careon April 30, 2024 at 1:50 pm
Walmart said clinics are not a sustainable business model due to a challenging reimbursement environment for primary care and increasing operating costs.
- Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiationson April 30, 2024 at 1:31 am
The decision is another win for the Biden administration in a bitter legal fight with several drugmakers over the constitutionality of the price talks.
- A CVS Health pharmacy in Vegas becomes first to join new national pharmacy unionon April 26, 2024 at 7:44 pm
Dozens of pharmacy staff at the Las Vegas branch of CVS's Omnicare will now join the Pharmacy Guild, which will represent them in labor negotiations with CVS.
- FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorderon April 26, 2024 at 1:22 pm
The agency greenlighted the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
- Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly losson April 25, 2024 at 4:26 pm
Bristol Myers Squibb said the charges primarily reflect its acquisition of Karuna Therapeutics and collaboration agreement with SystImmune.
- Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine saleson April 25, 2024 at 3:12 pm
The first-quarter results come as Merck shows substantial progress in preparing for Keytruda's patent expiration in 2028.
Click Advertiser ♥
-
-
-
-